Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Capture-C analysis of RCC-susceptibility loci in 786O renal cancer cell line

ABSTRACT: Capture-C analysis of RCC-susceptibility loci in 786O renal cancer cell line

PROVIDER: PRJNA542175 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR9037141_1.fastq.gz	Fastqsanger.gz
	SRR9037141_2.fastq.gz	Fastqsanger.gz
	SRR9037142_1.fastq.gz	Fastqsanger.gz
	SRR9037142_2.fastq.gz	Fastqsanger.gz
	SRR9037143_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 6

Similar Datasets

Capture-C analysis of RCC-susceptibility loci in 786O renal cancer cell line

Project description:Analysis of chromatin looping identies gene promoters that interact with enhancers and HIF-binding sites at kidney cancer-associated susceptibility loci

2019-12-31 | GSE130988 | GEO

miRNA expression of Tubulocystic Renal Cell Carcinoma (TC-RCC) cases

Project description:Eleven TC-RCC cases were selected on the basis of the criteria defined by the 2012 Vancouver Classification of Renal Neoplasia and WHO 2016 classification criteria, and re-reviewed by a panel of expert renal pathologists. Two of these cases, TC-RCC#9 and #10, had a mixed tubulocystic and papillary histology and were macro-dissected into separate PRCC and TC-RCC components. The molecular basis of TC-RCC, and miRNA expression profile, is unknown. We therefore used Affymetrix miRNA v.2. arrays to elucidate the expression of these samples

2017-07-19 | GSE101563 | GEO

Renal cells Carcinoma (RCC) Genome variation profiling by genome tiling array with Nimblegen CGX6 platform

Project description:Papillary renal cell carcinoma (pRCC) is the second most frequent renal cell carcinomas (RCC) after clear cell RCC. In contrast to clear cell RCC, there is no consensual protocol using targeted therapy for metastatic pRCC. Moreover, diagnosis of some pRCC, especially pRCC of type 2 (pRCC2) may be challenging. Our aim was to identify molecular biomarkers that could be helpful for the diagnosis and treatment of pRCC.

2014-11-06 | GSE63001 | GEO

Renal cells Carcinoma (RCC) Genome variation profiling by genome tiling array with Agilent CGH array

2014-11-06 | GSE63000 | GEO

Renal cells Carcinoma (RCC) Genome variation profiling by genome tiling array with Perkin Elmer Constituionnal Chip platform

2014-11-06 | GSE63002 | GEO

Renal cells Carcinoma (RCC) Genome variation profiling by genome tiling array with Agilent CGH array

2014-11-06 | E-GEOD-63000 | biostudies-arrayexpress

Biology of Renal Carcinoma using a Mouse RCC model

Project description:Biology of Renal Carcinoma using a Mouse RCC model

| PRJNA579344 | ENA

Renal Cell Carcinoma (RCC) tumorgrafts exhibit similar gene expression profiling to corresponding primary tumors

Project description:Primary tumors of Renal Cell Carcinoma (RCC) were implanted orthotopically into mice and their gene expression profiling was compared to their corresponding tumors using Affymetrix Human Genome U133 Plus 2.0 arrays.

2012-06-05 | E-MTAB-1050 | biostudies-arrayexpress

Study the role of miRNAs in metastasis progression of RCC cell lines

Project description:This study investigates for the miRNAs that drive or regulates Renal Cell Carcinoma (RCC) metastatic progression using two different RCC cell lines, the metastatic (LM2 and LM1) and non-metastatic (SN12C). The experiment is designed with three RCC cell lines one non-metastatic (SN12C) and two metastatic (LM1 and LM2). Each cell line has two biological replicates (exception SN12C has 3 replicates)

2010-08-19 | E-GEOD-23690 | biostudies-arrayexpress

Renal Cell Carcinoma (RCC) tumorgrafts exhibit similar DNA copy number alterations to corresponding primary tumors

Project description:Primary tumors of Renal Cell Carcinoma (RCC) were implanted orthotopically into mice and their DNA copy number abnormalities were compared to their corresponding tumors using Affymetrix SNP arrays 6.0

2012-06-05 | E-MTAB-1051 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data